Jarl Hellman
Kursledare vid Institutionen för medicinska vetenskaper; Grundutbildning
- Telefon:
- 018-611 43 41
- Mobiltelefon:
- 070-650 55 75
- E-post:
- jarl.hellman@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
- Akademiska meriter:
- Överläkare, Excellent lärare, Programstudierektor
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Urval av publikationer
- Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI (2024)
- Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms (2023)
- Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice (2023)
- Treatment Satisfaction and Well-Being With CGM in People With T1D (2023)
- Endokrinologi (2021)
- Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI (2021)
- The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring (2021)
- Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020)
- Tekniska innovationer i diabetesvården (2020)
- The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections (2020)
- EPA (2019)
- Treating diabetes with islet transplantation (2019)
- A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) (2018)
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial (2017)
- Impact of continuous subcutaneous insulin infusion on diabetes related complications and associated costs in type 2 diabetes patients in sweden (2016)
- Cost savings associated with CSII therapy compared to MDI in a Swedish setting (2015)
- Inctretin-based treatment of diabetes realted to cystic fibrosis (2014)
Senaste publikationer
- Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes (2024)
- Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI (2024)
- Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms (2023)
- Entrustable professional activities (EPAs) for undergraduate medical education (2023)
- Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice (2023)
Alla publikationer
Artiklar
- Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes (2024)
- Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI (2024)
- Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms (2023)
- Entrustable professional activities (EPAs) for undergraduate medical education (2023)
- Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice (2023)
- Treatment Satisfaction and Well-Being With CGM in People With T1D (2023)
- Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI (2021)
- The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring (2021)
- Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020)
- The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections (2020)
- EPA (2019)
- A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) (2018)
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial (2017)
- Impact of continuous subcutaneous insulin infusion on diabetes related complications and associated costs in type 2 diabetes patients in sweden (2016)
- Cost savings associated with CSII therapy compared to MDI in a Swedish setting (2015)
- Inctretin-based treatment of diabetes realted to cystic fibrosis (2014)
Kapitel
